South Korean beauty tech firm APR has posted record quarterly sales of KRW 593.4 billion (USD 450 million) in Q1 2026, driven by a 180% surge in overseas revenue. The company's MedyCube cosmetics and AGE-R beauty devices are gaining traction in the US, where sales jumped 251% year-on-year to KRW 248.5 billion. For overseas buyers, APR's expanding US retail footprint—including Target and Walmart—signals growing demand for integrated home-care beauty solutions.
Record financial performance
APR reported consolidated 2025 annual sales of KRW 1.53 trillion (USD 1.16 billion), up 111% year-on-year, with operating profit of KRW 365.4 billion, a 198% increase. In Q1 2026, sales reached KRW 593.4 billion and operating profit KRW 152.3 billion, both all-time quarterly highs. The company has sustained 11 consecutive years of growth since its founding.
Overseas expansion drives results
International sales accounted for 89% of total Q1 revenue, reaching KRW 528.1 billion. The US market generated KRW 248.5 billion, up 251% year-on-year, becoming APR's core market. Japan contributed KRW 58.9 billion (+101%), and other regions KRW 190 billion (+216%). APR's MedyCube brand entered Sephora channels across 17 European countries in March 2026 and signed a strategic partnership with India's largest beauty platform, Nykaa.
Product milestones and device growth
![메디큐브 화장품 및 뷰티 디바이스 주요 제품. [제공=에이피알]](https://cdn.shinailbo.co.kr/news/photo/202606/5028093_2026754_5112.jpg)
MedyCube's PDRN product line surpassed 50 million units globally in February 2026, just 20 months after launch. The toner pad line exceeded 20 million units by end-2025, and the Collagen Night Wrapping Mask reached 10 million units by April 2026. Beauty device sales hit a record KRW 132.7 billion in Q1 2026, with APR building a full lineup from cleansing to contouring based on in-house R&D and manufacturing.
What buyers should watch
APR is deepening its US offline presence: MedyCube entered over 1,500 Target stores in April 2026 and will expand to 3,000 Walmart locations this month. The company's strategy of pairing AGE-R devices with skincare products—such as the new Booster Glow designed for use with capsule creams—creates cross-selling opportunities. However, reliance on the MedyCube brand remains a risk; APR is diversifying into new categories and channels to sustain growth.
Sourcing context
For overseas distributors and clinic buyers, APR's integrated device-and-skincare model offers a ready-to-sell home-care system. The company's proprietary manufacturing and logistics infrastructure supports consistent supply. As APR targets Europe and Southeast Asia, importers should monitor its channel expansion and new product launches for potential partnership opportunities.
Source: Read the original report | Published: June 09, 2026
